But it's not close enough to perfect and they didn't factor a failure into the costs. So now there's pressure in not doing a second trial run that may or not be perfect because they don't want to lose money.

Not only that but it's year later than planned and has failed most of its tests. And even if everything had worked as planned it would have lost money.

It's really not a very successful philosophy anymore.